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the Total SGRQ score (r= 0.73) and Symptoms (r= 0.62); Activity (r= 0.55), Impact 
(r= 0.72) subscales; the modified MRC Dyspnoea scale (r= 0.54), FACIT-F (r= -0.66); 
HADS Anxiety (r= 0.53) and Depression (r= 0.54). The MEMSI also demonstrated good 
overall fit to the Rasch model (Chi-squared 26.6; df 20; p= 0.26) and distribution of item 
scores. ConClusions: The final MEMSI contains 10-item and is a reliable, valid, uni-
dimensional self-reported outcome measure of early morning symptoms for people 
with COPD. It is quick and simple making it suitable for use in research and practice. 
Further work is underway to determine the minimal clinical important difference.
PRM164
An ElEctRonic VERsion of thE Pdq-39: AccEPtAbility to REsPondEnts 
And AssEssMEnt of AltERnAtiVE REsPonsE foRMAts
Morley D., Dummett S., Kelly L., Dawson J., Jenkinson C.
University of Oxford, Headington, UK
objeCtives: Firstly, to migrate the paper-based version of the PDQ-39 to a computer 
based platform and assess its usability and acceptability to respondents. Secondly, 
to investigate the impact of implementing non-response options on response rates 
and data completeness. Methods: Six people with Parkinson’s (PwP) participated 
in cognitive interviews in order to assess the usability and acceptability of the 
electronic version of the PDQ-39, the ePDQ. This was followed by an online survey 
of 129 PwP, randomly assigned to one of two groups; one required to provide a 
response to every item and one with the option to skip any item they did not wish to 
answer. Results: Cognitive interviews indicated that the ePDQ is acceptable to PwP, 
with positive feedback regarding layout, features and functionality. 125 PwP fully 
completed the ePDQ. Following randomization 60 participants completed the forced 
response ePDQ and 65 completed the non-forced version. Response rates of 98.4% 
were achieved for the forced response ePDQ and 95.6% for the non-forced. Missing 
value analyses calculated levels of missing data at below 5% in the non-forced 
sample. ConClusions: The ePDQ is user-friendly and acceptable to respondents. 
Additionally, there appears little difference when implementing non-response 
options on response rates and data completeness.
PRM165
EfficAcy of ViRtuAl REAlity ExPosuRE thERAPy in thE MAnAgEMEnt of 
syMPtoMs AssociAtEd With Post tRAuMAtic stREss disoRdER
Jiandani N., Nair S.R., Shukla H.
Capita India Pvt. Ltd., Mumbai, India
objeCtives: Management of symptoms and illness for post traumatic stress dis-
order (PTSD) requires effective and prolonged psychiatric support. Re-experiencing 
traumatic memories and events via virtual reality exposure therapy (VRET) can 
lead to reduction of illness and symptoms associated with PTSD. This systematic 
literature review aims to demonstrate the value of VRET in the management of 
illness and symptoms associated with PTSD. Methods: Studies published in the 
English language for PTSD and VRET were retrieved from Embase, PubMed, and 
Cochrane databases using relevant search strategies. Two researchers are indepen-
dently reviewing studies as per the Cochrane methodology for systematic literature 
reviews. We considered VRET as a tool to deliver therapy programs via a virtual 
platform to patients suffering from PTSD. The main outcome will be improvement in 
symptoms such as anxiety, various phobias and depression developed as a result of 
PTSD. Outcomes will be measured as change in baseline characteristics in patients 
using VRET, by using questionnaires specific to the symptoms being measured 
such as Beck’s Anxiety Inventory, Beck’s Depression inventory-II (BDI-II), Clinician-
Administered PTSD Scale (CAPS), and patient reported outcomes. Results: In total, 
2574 potentially relevant studies were retrieved from the databases and are being 
screened for inclusion in the review. The detailed results from the systematic review 
will be presented in the poster. ConClusions: The evidence from this systematic 
literature review will hopefully suggest the role of VRET as a promising new tool for 
managing PTSD from a psychotherapeutic perspective.
PRM166
quAlity of lifE ElEMEnts in schizoPhREniA foR PAtiEnts And cARERs 
offER chAllEngEs to And oPPoRtunitiEs foR intERVEntion
Floyd D.1, Gemmell E.2, Brown J.1
1PHMR Associates, London, UK, 2PHMR Associates, Newcastle upon Tyne, UK
objeCtives: Schizophrenia is responsible for high levels of individual morbidity: 
acute schizophrenia had the highest disability score of any condition in the 2010 
Global Burden of Disease study. Consequently, quality of life (QoL) overall and related 
to health is a major issue for patients, as well as their families/carers. Methods: 
We undertook a pragmatic literature search of publications relating to QoL and 
schizophrenia over the past 7 years to identify main themes and trends. Results: 
Patients: Patient-reported QoL is often over-estimated compared to objective QoL as 
measured by health care professions, particularly during psychotic episodes. Factors 
that appear to be adversely associated with QoL include symptoms, treatment side 
effects, physical mobility, lack of relationships, daily activity, housing, social stigma 
and self-stigma. In some cases, there is a complex cause and effect relationship. 
Families/carers: Those looking after patients with schizophrenia suffer impaired 
QoL and this can have an impact on the whole household and its social milieu. 
Poor carer QoL can ultimately impair levels of care and increase risk of mistreat-
ment, which in turn risks a relapse of symptoms and ultimately hospitalisation. 
On the other hand, the experience of caring for a patient with schizophrenia may 
lead to personal emotional/psychological growth. Disease insight and education 
for some schizophrenia sufferers can lead to diminished QoL and an increased risk 
of suicide. On the other hand, disease understanding can help improve treatment 
adherence. ConClusions: QoL in schizophrenia is complicated and must be fully 
understood to help develop effective programmes to improve QoL for sufferers and 
their families/carers. Programmes that do not reflect this complexity may increase 
risk of symptom recurrence and even suicide. Thus, when devising interventional 
programmes to supplement drug treatment for management of schizophrenia, a 
range of patient- and carer-related factors must considered.
PRM161
AssEssing thE MEthodologicAl VAluE of digitAl REAl-tiME 
collEction of quAlitAtiVE contEnt in suPPoRting in-dEPth 
quAlitAtiVE intERViEWs ExPloRing thE syMPtoMs And iMPActs of 
gout on hEAlth-RElAtEd quAlity of lifE
Rudell K.1, Tatlock S.2, Panter C.2, Arbuckle R.2, Symonds T.1
1Pfizer Ltd, Tadworth, UK, 2Adelphi Values Ltd, Bollington, UK
objeCtives: Gout is the most common arthritic condition, but research of Gout 
patient experiences is limited. Qualitative interviews are a valid and well-accepted 
means of gaining in-depth insight into the patient experience, but are typically 
conducted in artificial environments relying on patient recall. Novel digital methods 
of collecting qualitative data through real-time data capture (RTDC) have recently 
emerged and have stronger ecological validity. The objective of this research was to 
assess the added methodological value of analyzing audio/visual data recorded and 
submitted by gout patients through a mobile phone application while experiencing 
flares, in addition to traditional patient interviews. Methods: Concept elicita-
tion interviews were conducted with 20 American gout patients using open-ended 
exploratory questions to facilitate spontaneous elicitation of content. Following 
interviews, 50% of the sample took part in a RTDC exercise by submitting self-
recorded videos and images in response to six tasks issued on a mobile phone 
application over seven days. All data were subject to thematic analysis using Atlas. 
ti. Interviews and RTDC data were compared in terms of conceptual coverage and 
insights. Results: Qualitative analysis demonstrated both forms of data collec-
tion led to the identification of the same symptoms and impacts with no additional 
concepts identified in either form of data. Symptoms and impacts of the disease 
during flares were high. RTDC data provided additional insight into the severity of 
symptoms and level of impact burden, specifically with regards to images of the 
level of swelling experienced during a flare and sleep disturbances through videos 
recorded by patients at the time of disturbance. ConClusions: Whilst traditional 
patient interviews remain the gold standard in exploring the symptoms and impacts 
of a condition, RTDC was found to provide additional valuable insights in this sam-
ple of gout patients, which can inform future measurement strategies and enhance 
the field of patient-centered research.
PRM162
WhAt is thE APPRoPRiAtE coMPARAtoR hEAlth stAtE to usE in tiME 
tRAdE-off studiEs?
Shah K.
Office of Health Economics, London, UK
objeCtives: Studies to produce utility values for the EQ-5D-5L instrument are 
ongoing internationally. These include the valuation of 10 EQ-5D-5L health states 
using the time trade-off (TTO) method. In some of the studies carried out to date, 
relatively low mean TTO values for mild health states have been observed. It is 
hypothesised that this is because the health states under evaluation are being com-
pared to “full health”, whereas in previous studies they were compared to 11111 (the 
“best” health state in the descriptive system). The objective is to assess differences in 
TTO valuations using two different comparators (full health and 11111). Methods: 
Preferences for EQ-5D-5L health states were elicited from a broadly representative 
sample of the UK general public. TTO data were collected using computer-assisted 
personal interviews, carried out in respondents’ homes. Respondents were ran-
domly allocated to one of two arms: in arm 1 the comparator health state was full 
health; in arm 2 the comparator health state was 11111. After completing 10 TTO 
valuations, respondents were asked follow-up questions which sought to examine 
their interpretations of the term “full health”. Results: 450 interviews were com-
pleted in mid-2014. Health state 11111 was almost always given a value of 1; yet 
the majority of respondents who self-reported as being in 11111 did not consider 
themselves to be in “best imaginable health”. Preliminary analyses suggest that 
the use of 11111 (rather than full health) as the comparator does not increase the 
average values elicited for mild health states. A sizeable minority of respondents 
did not agree that 11111 and full health are equivalent. Vision and spirituality were 
mentioned by respondents as examples of important aspects of health not covered 
by 11111. ConClusions: The low observed values for mild EQ-5D-5L health states 
cannot be explained by the choice of comparator health state alone.
PRM163
thE dEVEloPMEnt And PREliMinARy VAlidAtion of thE MAnchEstER 
EARly MoRning syMPtoMs indEx (MEMsi) foR PEoPlE With chRonic 
obstRuctiVE PulMonARy disEAsE (coPd)
Garrow A.P.1, Yorke J.1, Khan N.2, Tyson S.1, Singh D.3, Vestbo J.4
1University of Manchester, Manchester, UK, 2The Medicines Evaluation Unit, Manchester, UK, 
3University of Manchester, Medicines Evaluation Unit, Manchester, UK, 4The University of 
Manchester, Manchester, UK
objeCtives: Early morning symptoms (EMS) of COPD are associated with poor 
health, impaired daily activities and increased exacerbation risk. We describe the 
development and preliminary validation of the Manchester Early Morning Symptom 
Index (MEMSI) to quantify EMS in COPD. Methods: Potential items were identified 
from interviews and focus groups with COPD and non-COPD participants. Cognitive 
de-briefing elucidated the relevance and understanding of the potential items fol-
lowed by a cross-sectional study to finalise the items for inclusion. The draft scale 
was completed twice, one week apart to assess test-retest reliability. The St George’s 
Respiratory Questionnaire (SGRQ), modified MRC Dyspnoea Scale, FACIT fatigue scale 
and Hospital Anxiety and Depression Scale (HADS) evaluated convergent validity. 
Hierarchical methods and Rasch analysis informed item reduction and assessed 
uni-dimensionality. Results: 36 patients with COPD initially identified 22 items. 
The cross sectional study included 203 COPD patients (GOLD: I: 14% II: 41% III: 25% 
IV: 7%, male: 63%, mean age 64.7, SD: 7.5 years) and 50 age and gender matched 
non-COPD controls. 12 items were removed during hierarchical methods. The MEMSI 
demonstrated excellent internal consistency (Cronbach’s alpha 0.9) and good test-
retest repeatability (r= 0.82). The scale also showed moderate-good correlation with 
 VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 3 2 3 – A 6 8 6  A573
models. A checklist based on critiques of recent HTAs will be a useful tool for manu-
facturers when selecting relevant HRQoL parameters.
PRM170
tRAnslAtion And linguistic VAlidAtion of thE ElEctRonic coloMbiA 
suicidE sEVERity RAting scAlE in AsiA-PAc
Anderson H.1, Gordon-Stables R.1, Wild D.1, Riale K.2
1ICON Plc, Oxford, UK, 2ERT, Pittsburgh, PA, USA
objeCtives: The Columbia Suicide Severity Rating Scale (C-SSRS) has been devel-
oped into an electronic self-rated version (the e-CSSRS) in order to facilitate compli-
ance with regulatory requirements for prospective monitoring of suicidal ideation 
and behaviours. The e-CSSRS v2.0 for IVRS has been translated and linguistically 
validated for use in over 60 countries. Whilst translating and linguistically validating 
the scale it was noted that particularly in the Asia-Pacific region there were some 
challenging issues around the concept of suicide from a linguistic and cultural 
perspective. This study aimed to determine what these issues were and highlight 
how they were resolved. Methods: Eighteen reports were reviewed from the Asia-
Pacific region. The languages were: China-Mandarin, India-English, India-Gujarati, 
India-Hindi, India-Kannada, India-Malayalam, India-Marathi, India-Tamil, India-
Telugu, Korea-Korean, Malaysia-English, Malaysia-Malay, Malaysia-Mandarin, 
Philippines-English, Philippines-Tagalog, Singapore-English, Singapore-Malay, and 
Singapore-Mandarin. Each report was reviewed for challenges relating to translation 
and cultural adaptation. Results: Across all reports specific homonymic confu-
sions were encountered within two target languages: in Indian Hindi the same 
word is used for “pill” and “bullet”; in Singapore Malay the words for “end” and 
“saving” sound similar, occasioning confusion in prompts about attempts to end 
life. Translations were adapted to avoid these confusions. In two cases the use of 
a gun in suicide attempts was found to be rare or unknown: in Singapore English 
the relevant prompt was clarified to minimise confusion; for Malayalam for Kerala, 
where shooting is rare and hanging is common, “getting a gun” was changed to 
“getting a rope” wherever it appeared and for similar reasons “collecting pills” was 
changed to “collecting a poison.” ConClusions: The e-CSSRS v2.0 IVRS is now 
available in for use in over 60 countries. Some issues were identified relating to 
translation and the methods of suicide in a small number of languages but these 
were resolved throughout the linguistic validation process.
PRM171
fRoM clinicAlly RElEVAnt outcoME MEAsuREs to quAlity of lifE  
in EPilEPsy
de Kinderen R.J.A.1, Wijnen B.F.M.1, Postulart D.2, Majoie M.H.2, Aldenkamp A.P.2, Evers S.M.1
1Maastricht University, Maastricht, The Netherlands, 2Epilepsy Center Kempenhaeghe, Heeze, The 
Netherlands
objeCtives: Utilities can be easily derived using generic quality of life (QoL) instru-
ments. However, problems in collecting utility scores may occur because clinical 
evaluations still favor disease specific instruments over generic quality of life instru-
ments for reasons of sensitivity and reliability. Especially in case of the fluctuating 
nature of seizures in epilepsy, generic QoL-instruments are often find to be unsuit-
able for outcome research. A proposed method to bridge the gap between clinically 
relevant outcome measures and QoL is to derive utility scores for epilepsy health 
states. The aim of this study is to develop a scoring algorithm to transform epilepsy 
health states into utility scores. Methods: The proposed scoring algorithm was 
based on valuations of health states generated by the Time Trade-Off (TTO) method. 
The TTO was based on clinically important attributes (seizure frequency, seizure 
severity and treatment related side-effects). A full factorial design was used which 
resulted in 78 scenario’s. Besides standard demographics, every participant was 
asked to value 10 or 11 different health states. A multilevel regression analysis was 
performed to account for the nested structure of the data. The TTO was conducted 
using online survey software. Results: In total 531 subjects of the general popula-
tion, with an average age of 42 years, have participated in the TTO study. Preliminary 
results show that the best health state (no seizures and no side-effects) is estimated 
at 0.89 utility and the worst state (seizures twice a day, many side-effects, type 5 
seizure) is estimated at 0.16. ConClusions: This study provides a scoring algo-
rithm for transforming clinically relevant outcome measures of epilepsy into utility 
estimates which can be incorporated into economic evaluations. Although seizure 
frequency is the most commonly reported primary outcome measure in epilepsy 
research, this study suggest that the impact of seizure severity alone should not 
be underestimated.
PRM172
An AnAlysis of thE hEAlth tEchnology AssEssMEnt REcoMMEndAtion 
And guidAncE on usE of Eq-5d-5l in cost-EffEctiVEnEss ModEling
Ovcinnikova O.1, Firth Z.A.2, Dimova M.2
1MAPI, London, UK, 2Mapi, London, UK
objeCtives: Several national health technology assessment (HTA) bodies including 
the National Institute for Health and Care Excellence (NICE) for England and Wales 
recommend EQ-5D as the preferred health-related quality of life (HRQL) measure for 
use in cost-effectiveness analyses. This study aims to evaluate the recommendation 
and impact of using EQ-5D-5L versus EQ-5D-3L for cost-effectiveness modeling in 
HTA submission guidelines and subsequent reimbursement decisions. Methods: 
A targeted review of national HTA submission modeling guidelines since the intro-
duction of the EQ-5D-5L measure was carried out for the UK and France. The cost-
effectiveness modeling guidelines were assessed for the requirements for EQ-5D at 
either level. The impact of guideline requirements on submissions were analysed 
by examining the presence of EQ-5D-5L in the 20 most recent technical appraisal 
manufacturer submissions for each HTA body. Results: While all HTA bodies rec-
ommended the use of EQ-5D as a generic measure of HRQL, only NICE specifically 
recommended EQ-5D-5L. However, it was not a requirement. Of the latest published 
guidance only NICE and the Scottish Medicines Consortium had one EQ-5D-5L sub-
mission each. Despite evidence suggesting increased sensitivity and reduced ceiling 
PRM167
coMPARAbility of intERViEW And sElf-AdMinistRAtion of thE 
functionAl AssEssMEnt of chRonic illnEss thERAPy-tubERculosis 
(fAcit-tb) instRuMEnt in iRAqi PulMonARy tubERculosis PAtiEnts
Dujaili J.A.1, Syed Sulaiman S.A.1, Hassali M.A.2, Blebil A.Q.3, Awaisu A.4, Bredle J.M.5
1Universiti Sains Malaysia, Minden, Malaysia, 2Universiti Sains Malaysia, Penang, Malaysia, 
3UCSI University, Kuala Lumpur, Malaysia, 4Qatar University, Doha, Qatar, 5FACITtrans, 
Elmhurst, IL, USA
objeCtives: To investigate the extent to which two different modes of adminis-
tration (interview by a trained interviewer versus self-administration) yielded a 
comparable estimate of health-related quality of life (HRQL) in pulmonary tuber-
culosis (PTB) patients. Methods: The study was conducted between September 
1st 2012 and July 31st 2013, among consecutive PTB patients treated at Thoracic and 
Respiratory Disease Specialist Centre in Baghdad, Iraq. The mode of administration 
of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB); 
a new tuberculosis (TB) -specific instrument, at baseline was registered in 305 sub-
jects. Results: Although the FACIT-TB was designed for self-administration, most 
patients in our sample (N = 193,63.278%) requested some help from the interviewer 
to fill out the questionnaire. Mann Whitney U test showed that those patients capa-
ble of self-administration were younger (38.16 ± 12.93 versus 43.58 ± 16.41 years, P 
= 0.005) and required less time to complete the questionnaire compared to those 
who interviewed by a trained interviewer (14.64 ± 3.24 versus 17.22 ± 2.61 minutes, 
P < 0.001), while Chi-Square statistics showed that this group of patients had a 
higher education level (P < 0.001). No differences in gender were observed. HRQL 
score across all domains for those who interviewed by a trained investigator was 
slightly lower than those who answered the questionnaire by self-administration. 
However, the results did not reach statistical significance (P> 0.05). ConClusions: 
Technical equivalence has been demonstrated in the sample of PTB patients in Iraq. 
FACIT-TB instrument is flexible and it is able to accommodate the needs of patients 
with diverse social, educational, and functional skills. Technical equivalence across 
different modes of administration of questionnaire permits unbiased assessment 
of the impact of the disease and its treatments on patients’ HRQL.
PRM168
hEAlth RElAtEd quAlity of lifE in cAncER PAtiEnts: EVAluAtion With 
A sElf-AdMinistEREd iPAd APPlicAtion
Yuce D., Hayran M., Kilickap S., Erman M., Celik I.
Hacettepe University, Ankara, Turkey
objeCtives: Cancer has the second highest mortality rates after cardiovascular dis-
eases in the world. Advances in treatment options caused significant enhancements 
in survival of cancer patients. However, the major parameter affecting treatment 
success and treatment adherence in these patients is the quality of life (QoL). We 
aimed to develop a self-administered iPad application for evaluation of QoL in a 
short questionnaire. Methods: As part of routine practice in Preventive Oncology 
Department EORTC QLQ-C30 was administered to 1549 cancer patients treated in 
Hacettepe University Oncology Hospital. We determined 10 questions that explains 
most of the variation in QoL using factor analysis, and designed a new application 
for iPad, where patients can record responses themselves. Results: The 10 factors 
that described by the factor analysis had the power of 74,2% explaining QoL vari-
ances. The reliability analysis of these factors showed a Cronbach alpha coefficient 
of 0,75. The new self-administered iPad application was tested in a pilot study that 
conducted in 127 patients taking chemotherapy regimens in the outpatient setting. 
The validity and reliability analyses revealed that the new application can be effec-
tively used in Turkish cancer patients. ConClusions: Our results revealed that our 
software application will be useful and efficient for monitoring of the changes in 
QoL during their treatment course. Furthermore, this kind of mobile applications 
may be practical for health professionals in daily routine clinical assessments of 
patients. Also, the audio and visual enhancements in electronic applications provide 
increased accessibility for the cancer patients.
PRM169
thE sElEction of APPRoPRiAtE hEAlth stAtE utility VAluEs (hsuVs) foR 
hEAlth tEchnology AssEssMEnt (htA): lEssons to bE lEARnt
Patel A., King D., Greenall G., Mitchell S.A., Purushotham S., Hudson P.M.
Abacus International, Bicester, UK
objeCtives: Incorporation of health-related quality of life (HRQoL) evidence into 
economic models is a requirement of many countries for the purposes of Health 
Technology Assessment (HTA), and therefore appropriate health state utility values 
(HSUVs) are often sought. The objective of this review was to: (i) identify and sum-
marise the principal limitations of HSUVs used in recent submissions appraised 
by the National Institute for Health and Care Excellence (NICE) and (ii) produce 
a categorical checklist that can be used by manufacturers to reduce uncertainty 
when selecting HSUVs for HTA. Methods: Evidence appraisal documents for the 
50 most recently published technologies assessed by NICE were retrieved in June 
2014. Economic models were assessed and utility inputs reviewed. Critiques of the 
utilities reported by the evidence review group or final appraisal committee were 
extracted, reviewed and categorised. Results: Of the appraisals reviewed (43 single 
technology appraisals (TAs) and 7 multiple TAs), utility inputs were either sourced 
from the literature (n= 27), published mapping algorithms (n= 11), de novo mapping 
algorithms (n= 2), or derived from clinical trials (n= 10). The concerns expressed by 
review groups can be categorised into four categories: (i) generalisability – relevance 
of HSUVs to UK clinical practice, deviation from NICE scope, and the use of other 
countries’ valuations for health states; (ii) HSUV selection – inadequate justification 
of HSUVs, and lack of consideration for covariates and disutilities; (iii) mapping algo-
rithms – use of non-validated or non-peer-reviewed publications, incomplete report-
ing of key model information, and ambiguity regarding selection and justification 
of mapping function; (iv) risk of bias – sample size, instrument response rates, and 
general study quality identified as factors affecting HSUV validity. ConClusions: 
The selection of appropriate HSUVs is critical to reduce uncertainty in economic 
